Insulin-like growth factor-I partially attenuates colonic damage in rats with experimental colitis induced by oral dextran sulphate sodium

Scandinavian Journal of Gastroenterology

Volumn 33, Issue 2, 1998, Pages 180-190

  Howarth, G S ^a   Xian, C J ^a   Read, L C ^a  

^a CHILD HEALTH RESEARCH INSTITUTE   (Australia)

Author keywords

Animal model; Colonic inflammation; Insulin like growth factor; Rats; Transforming growth factor 1; Ulcerative colitis

Indexed keywords

DEXTRAN SULFATE; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLITIS; COLON INJURY; COLON MUCOSA; GOBLET CELL; HISTOPATHOLOGY; LAMINA PROPRIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBMUCOSA;

ANIMALS; BODY WEIGHT; COLITIS, ULCERATIVE; COLON; DEXTRAN SULFATE; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR I; INTESTINAL MUCOSA; MALE; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031884321     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365529850166923     Document Type: Article

References (41)

1. Jewell DP, Chapman RGW, Mortensen N. Ulcerative colitis and Crohn's disease, a clinician's guide. London: Churchill Livingstone; 1992. p. 1-79.
2. Hanauer SB. Medical therapy in ulcerative colitis. In: Kirsner JB, Shorter RG, editors. Inflammatory bowel disease. 4th ed. Baltimore: Williams and Wilkins; 1995. p. 664-94.
3. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990;98:694-702.
4. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993;69:238-49.
5. Bylund-Fellenius A-C, Axelsson L-G, Landstrom E. Protective effect of sulphasalazine and olsalazine in dextran sulfate (DSS)-induced colitis in the mouse [abstract]. Gastroenterology 1992; 102:A600.
6. Murthy SN, Cooper HS, Shim H, Shah RS, Ibrahim SA, Sedergran DJ. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig Dis Sci 1993; 38:1722-34.
7. Pentney PT, Bubenik GA. Melatonin reduces the severity of dextran-induced colitis in mice. J Pineal Res 1995;19:31-9.
8. Takizawa H, Shintani N, Natsui M, Sasakawa T, Nakakubo H, Nakajima T, et al. Activated immunocompetent cells in rat colitis mucosa induced by dextran sulfate sodium and not complete but partial suppression of colitis by FK506. Digestion 1995;56:259-64.
9. Murthy SNS, Fondacaro JD, Murthy NS, Cooper HS, Bolkenius F. Beneficial effect of MDL 73404 in dextran sulfate-mediated murine colitis. Agents Actions 1994;41:C233-4.
10. Murthy S, Cooper H, Coppola D, Shirer R. Interleukin-1 receptor antagonist is effective against dextran sulfate (DSS)-mediated colitis in mice [abstract]. Gastroenterology 1992;102: A669.
11. Domek MJ, Iwata F, Blackman EI, Kao J, Baker M, Vidrich A, et al. Anti-neutrophil serum attenuates dextran sulfate sodium-induced colonic damage in the rat. Scand J Gastroenterol 1995; 30:1089-94.
12. Luck MS, Bass P. Effect of epidermal growth factor on experimental colitis in the rat. Pharmacol Exp Ther 1993;264:984-90.
13. Procaccino F, Reinshagen M, Hoffmann P, Zeeh JM, Lakshmanan J, McRoberts JA, et al. Protective effect of epidermal growth factor in an experimental model of colitis in rats. Gastroenterology 1994;107:12-7.
14. Sandor Z, Kusstatscher S, Szeli D, Szabo S. The effect of thrombocyte-derived growth factor on experimental inflammatory bowel disease. Orv Hetil 1995;136:1059-61.
15. Zeeh JM, Procaccino F, Hoffmann P, Aukerman SL, McRoberts JA, Soltani S, et al. Keratinocyte growth factor ameliorates mucosal injury in an experimental model of colitis in rats. Gastroenterology 1996;110:1077-83.
16. Murthy S, Cooper H, Coppola D, Barish S, McKibbin R, Cerletti N, et al. Transforming growth factor beta2. but not epidermal growth factor, yields protection against dextran sulfate (DSS)-mediated colitis in mice [abstract]. Gastroenteroloey 1992;102: A669.
17. Christensen H, Flyvbjerg A, Orskov H, Laurberg S. Effect of growth hormone on the inflammatory activity of experimental colitis in rats [published erratum appears in Scand J Gastroenterol 1993;28:preceding 1025]. Scand J Gastroenterol 1993; 28:503-11.
18. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995;16:3-34.
19. Read LC, Lemmey AB, Howarth GS, Martin AA, Tomas FM, Ballard FJ. The gastrointestinal tract is one of the most responsive target tissues for IGF-I and its potent analogs. In: Spencer EM, editor. Modem concepts of insulin-like growth factors. Amsterdam: Elsevier Science Publishing Company Inc.; 1991. p. 225-34.
20. Read LC, Tomas FM, Howarth GS, Martin AA. Edson K. Owens PC, et al. IGF-I and its N-terminal modified analogs induced marked gut growth in dexamethasone-treated rats. J Endocrinol 1992;133:421-31.
21. Tomas FM, Knowles SE, Owens PC, Read LC, Chandler CS, Gargosky SE, et al. Increased weight gain, nitrogen retention and muscle protein synthesis following treatment of diabetic rats with insulin-like growth factor (IGF)-I and des(1-3)IGF-I. Biochem J 1991;276(Pt 2):547-54.
22. Lemmey AB, Martin AA, Read LC, Tomas FM, Owens PC, Ballard FJ. IGF-I and the truncated analogue des-(I-3)IGF-I enhance growth in rats after gut resection. Am J Physiol 1991;260(2 Pt 1):E213-9.
23. Steeb C-B, Trahair JF, Tomas FM, Read LC. Prolonged administration of IGF peptides enhances growth of gastrointestinal tissues in normal rats. Am J Physiol 1994;266(6 Pt 1):G1090-8.
24. Heinz-Erian P, Kessler U, Funk B, Gais P, Kiess W. Identification and in situ localization of the insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptor in the rat gastrointestinal tract: comparison with the IGF-I receptor. Endocrinology 1991;129:1769-78.
25. Zimmermann EM, Sartor RB, McCall RD, Pardo M, Bender D, Lund PK. Insulinlike growth factor I and interleukin 1 beta messenger RNA in a rat model of granulomatous enterocolitis and hepatitis. Gastroenterology 1993;105:399-409.
26. Zeeh JM, Hoffmann P, Sottili M, Eysselein VE, McRoberts JA. Up-regulation of insulinlike growth factor I binding sites in experimental colitis in rats. Gastroenterology 1995;108:644-52.
27. Howarth GS, Penning KA, Cool JC, Read LC. IGF-I and repair of the methotrexate-damaged small intestine. Growth Reg 1994;4:124 [abstract II 296].
28. Eisenstein EM, Strober W. Cytokines: key mediators of immunity and inflammation. In: Fiocchi C, editor. Cytokines in inflammatory bowel disease. Houston (TX): RG Lander Co.; 1996. p. 1-20.
29. Barnard JA III, Coffey RJ. Transforming growth factor-β. In: Walsh JH, Dockray GJ, editors. Gut peptides: biochemistry and physiology. New York: Raven; 1994. p. 615-31.
30. McCabe RP, Secrist H, Botney M, Egan M, Peters MG. Cytokine mRNA expression in intestine from normal and inflammatory bowel disease patients. Clin Immunol Immunopathol 1993;66:52-8.
31. Tomas FM, Knowles SE, Owens PC, Read LC, Chandler CS, Gargosky SE, et al. Effects of full-length and truncated insulin-like growth factor-I on nitrogen balance and muscle metabolism in nitrogen-restricted rats. J Endocrinol 1991;128:97-105.
32. Owens PC, Johnson RJ, Campbell RG, Ballard FJ. Growth hormone increases insulin-like growth factor-I (IGF-I) and decreases IGF-II in plasma of growing pigs. J Endocrinol 1990; 124:269-75.
33. 3IGF-I in pregnant rats. J Endocrinol 1993;138:327-36.
34. Yang YW, Brown AL, Orlowski CC, Graham DE, Tseng LY-H, Romanus JA, et al. Identification of rat cell lines that preferentially express insulin-like growth factor binding proteins rIGF-1, 2 or 3. Mol Endocrinol 1990;4:29-138.
35. Dieleman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP, Elson CO. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994; 107:1643-52.
36. Ni J, Chen SF, Hollander D. Effects of dextran sulphate sodium on intestinal epithelial cells and intestinal lymphocytes. Gut 1990;39:234-41.
37. Steeb C-B, Trahair JF, Read LC. Administration of insulin-like growth factor-I (IGF-I) peptides for three days stimulates proliferation of the small intestinal epithelium in rats. Gut 1995;37:630-8.
38. Bhora FY, Dunkin BJ, Batzri S, Aly HM, Bass BL, Sidawy AN, et al. Effect of growth factors on cell proliferation and epithelialization in human skin. J Surg Res 1995;59:236-44.
39. Ghahary A, Shen YJ, Nedelec B, Scott PG, Tredget EE. Enhanced expression of mRNA for insulin-like growth factor-I in post-burn hypertrophic scar tissue and its fibrogenic role by dermal fibroblasts. Mol Cell Biochem 1995;148:25-32.
40. Vaillant P, Menard O, Vignaud J, Martinet N, Martinet Y. The role of cytokines in human lung fibrosis. Monaldi Arch Chest Dis 1996;51:145-52.
41. Cittadini A, Stromer H, Katz SE, Clark R, Moses AC, Morgan JP, et al. Differential cardiac effects of growth hormone and insulin-like growth factor-I in the rat. A combined in vivo and in vitro evaluation. Circulation 1996;93:800-9.